237 related articles for article (PubMed ID: 8281698)
1. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
Cohen M; Adams PC; Parry G; Xiong J; Chamberlain D; Wieczorek I; Fox KA; Chesebro JH; Strain J; Keller C
Circulation; 1994 Jan; 89(1):81-8. PubMed ID: 8281698
[TBL] [Abstract][Full Text] [Related]
2. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
Cohen M; Xiong J; Parry G; Adams PC; Chamberlain D; Wieczorek I; Fox KA; McBride R; Chesebro JH; Fuster V
J Am Coll Cardiol; 1993 Nov; 22(5):1338-43. PubMed ID: 7901254
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
Cohen M; Parry G; Adams PC; Xiong J; Chamberlain D; Wieczorek I; Fox KA; Kronmal R; Fuster V
Eur Heart J; 1994 Sep; 15(9):1196-203. PubMed ID: 7982419
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).
Cohen M; Adams PC; Hawkins L; Bach M; Fuster V
Am J Cardiol; 1990 Dec; 66(19):1287-92. PubMed ID: 2244556
[TBL] [Abstract][Full Text] [Related]
5. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
[TBL] [Abstract][Full Text] [Related]
6. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
Schreiber TL; Macina G; McNulty A; Bunnell P; Kikel M; Miller DH; Devereux RB; Tenney R; Cowley M; Zola B
Am J Cardiol; 1989 Oct; 64(14):840-4. PubMed ID: 2801550
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.
Gurfinkel EP; Manos EJ; Mejaíl RI; Cerdá MA; Duronto EA; García CN; Daroca AM; Mautner B
J Am Coll Cardiol; 1995 Aug; 26(2):313-8. PubMed ID: 7608429
[TBL] [Abstract][Full Text] [Related]
9. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.
Anand SS; Yusuf S; Pogue J; Weitz JI; Flather M
Circulation; 1998 Sep; 98(11):1064-70. PubMed ID: 9736592
[TBL] [Abstract][Full Text] [Related]
10. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.
Becker RC; Cannon CP; Tracy RP; Thompson B; Bovill EG; Desvigne-Nickens P; Randall AM; Knatternud G; Braunwald E
Am Heart J; 1996 Mar; 131(3):421-33. PubMed ID: 8604620
[TBL] [Abstract][Full Text] [Related]
11. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
Cohen M; Stinnett SS; Weatherley BD; Gurfinkel EP; Fromell GJ; Goodman SG; Fox KA; Califf RM
Am Heart J; 2000 Jun; 139(6):962-70. PubMed ID: 10827375
[TBL] [Abstract][Full Text] [Related]
12. Prospective Comparison of Patient Characteristics and Outcome of Non-prior Aspirin Users versus Aspirin Users with Unstable Angina or Non-Q-Wave Myocardial Infarction Treated with Combination Antithrombotic Therapy.
Cohen M; Adams PC; McBride R; Blanke H; Fuster V
J Thromb Thrombolysis; 1997; 4(2):275-280. PubMed ID: 10639270
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of thrombolysis versus heparin in unstable angina.
Schreiber TL; Rizik D; White C; Sharma GV; Cowley M; Macina G; Reddy PS; Kantounis L; Timmis GC; Margulis A
Circulation; 1992 Nov; 86(5):1407-14. PubMed ID: 1423953
[TBL] [Abstract][Full Text] [Related]
14. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.
Oler A; Whooley MA; Oler J; Grady D
JAMA; 1996 Sep; 276(10):811-5. PubMed ID: 8769591
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
Am J Cardiol; 1998 Sep; 82(5B):19L-24L. PubMed ID: 9737476
[TBL] [Abstract][Full Text] [Related]
16. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.
Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
N Engl J Med; 1998 May; 338(21):1498-505. PubMed ID: 9599104
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
[TBL] [Abstract][Full Text] [Related]
18. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.
Santopinto J; Gurfinkel EP; Torres V; Marcos E; Bozovich GE; Mautner B; McCabe CH; Antman EM
Am Heart J; 2001 Apr; 141(4):566-72. PubMed ID: 11275921
[TBL] [Abstract][Full Text] [Related]
19. Clinical and angiographic characteristics and outcome of patients with rest-unstable angina occurring during regular aspirin use.
Cohen M; Merino A; Hawkins L; Greenberg S; Fuster V
J Am Coll Cardiol; 1991 Nov; 18(6):1458-62. PubMed ID: 1939946
[TBL] [Abstract][Full Text] [Related]
20. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Pilot Study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation.
Anand SS
Am J Cardiol; 1999 Sep; 84(5A):13M-19M. PubMed ID: 10505538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
